Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Vitamin D3 Adjuvant Treatment Stimulate Interleukin-10 Expression in Children with Nephrotic Syndrome Without Affecting to Clinical Outcome and Glucocorticoid Receptor Expression

Journal of Tropical Life Science : International Journal of Theoretical, Experimental, and Applied Life Sciences · Vol. 4 No. 3 (2014) · hlm. 166–174

ISSN
2527-4376, 2087-5517
Terbit
2014-12-24
Penerbit
Journal of Tropical Life Science
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc/4.0

Abstrak

Idiopathic nephrotic syndrome (INS) is the most glomerular disease that occurred in childhood with high rate morbidity. Glucocorticoid is drug of choice for INS and responsiveness to this drug determined prognosis. Glucocorticoid upregulate transcription of anti-inflammatory cytokines such as IL-4 and IL-10. IL-10 is an anti-inflammatory cytokine and has multiple role in immune response include modulate Th1/Th2 response. Vitamin D3 interact with glucocorticoid signaling. Administered active form of vitamin D3 increase dexamethasone-induced IL-10 expression by regulatory T cells in steroid resistant asthmatic patient. Here we showed increase of CD4+IL10+ expression after treatment both prednisone only and combination prednison with vitamin D3. Both in new-onset NS or rare relaps NS, combination treatment prednisone + vitamin D3 increase CD4+IL10+ expression significantly compared to prednisone-only treated group (p= 0.003), which first group (new-onset nephrotic syndrome + prednisone and vitamin D3 treatment) showed the most CD4+IL10+ expression enhancement (9.53±3.89). However this study failed to show a correlation between CD4+IL-10+ expression after prednisone and vitamin D3 treatment with clinical outcome (linear regression test, p= 0,125). This study also showed that there was a no correlation between CD4+IL-10+ expression and CD3+GR expression after prednison + vitamin D3 treatment (p= 0.088). CD4+IL-10+expression in new-onset and rarely relapsing nephrotic syndrome patients higher in prednisone + vitamin D3 treated group than prednisone-only treated group. There is no correlation between CD4+IL-10+expression and CD3+GR expression nor CD4+IL-10+expression and clinical outcome.

Jaringan kolaborasi para penulis

27 penulis · 79 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • IPB University
  • University of Brawijaya
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sujarot Dwi SasmitoAfiliasi tidak diketahui2
Tikto WahyonoAfiliasi tidak diketahui2
Agustina Tri EndhartiAfiliasi tidak diketahui2
Yunika NurtyasUniversity of Brawijaya2
Karyono MintaroemAfiliasi tidak diketahui1
Desy AndariAfiliasi tidak diketahui1
Zainabur RahmaAfiliasi tidak diketahui1
Yuliyanik yuliyanikAfiliasi tidak diketahui1
Kusworini HandonoAfiliasi tidak diketahui1
Handono KalimAfiliasi tidak diketahui1
Laksmi Karunia TanuwijayaAfiliasi tidak diketahui1
Andi GunawanIPB University1
M MuidAfiliasi tidak diketahui1
Hidayat SuyudiAfiliasi tidak diketahui1
Barlianto wisnuAfiliasi tidak diketahui1
Adilah UlfiatiAfiliasi tidak diketahui1
Ardhian WardanaAfiliasi tidak diketahui1
Fitriana NugraheniAfiliasi tidak diketahui1
Nur Fahma PradiptasariAfiliasi tidak diketahui1
Zakiyah ZulaifaAfiliasi tidak diketahui1
Eviana NorahmawatiAfiliasi tidak diketahui1
Teguh Wahju SardjonoAfiliasi tidak diketahui1
Melda Fio Flora BR. SijabatAfiliasi tidak diketahui1
Tinny Endang HernowatiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://jtrolis.ub.ac.id/index.php/jtrolis/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Vitamin D3 Adjuvant Treatment Stimulate Interleukin-10 Expression in Children with Nephrotic Syndrome Without Affecting to Clinical Outcome and Glucocorticoid Receptor Expression</dc:title>
	<dc:creator xml:lang="en">Asariati, Husnul</dc:creator>
	<dc:creator xml:lang="en">Subandiyah, Krisni</dc:creator>
	<dc:creator xml:lang="en">Fitri, Loeki Enggar</dc:creator>
	<dc:description xml:lang="en">Idiopathic nephrotic syndrome (INS) is the most glomerular disease that occurred in childhood with high rate morbidity. Glucocorticoid is drug of choice for INS and responsiveness to this drug determined prognosis. Glucocorticoid upregulate transcription of anti-inflammatory cytokines such as IL-4 and IL-10. IL-10 is an anti-inflammatory cytokine and has multiple role in immune response include modulate Th1/Th2 response. Vitamin D3 interact with glucocorticoid signaling. Administered active form of vitamin D3 increase dexamethasone-induced IL-10 expression by regulatory T cells in steroid resistant asthmatic patient. Here we showed increase of CD4+IL10+ expression after treatment both prednisone only and combination prednison with vitamin D3. Both in new-onset NS or rare relaps NS, combination treatment prednisone + vitamin D3 increase CD4+IL10+ expression significantly compared to prednisone-only treated group (p= 0.003), which first group (new-onset nephrotic syndrome + prednisone and vitamin D3 treatment) showed the most CD4+IL10+ expression enhancement (9.53±3.89). However this study failed to show a correlation between CD4+IL-10+ expression after prednisone and vitamin D3 treatment with clinical outcome (linear regression test, p= 0,125). This study also showed that there was a no correlation between CD4+IL-10+ expression and CD3+GR expression after prednison + vitamin D3 treatment (p= 0.088). CD4+IL-10+expression in new-onset and rarely relapsing nephrotic syndrome patients higher in prednisone + vitamin D3 treated group than prednisone-only treated group. There is no correlation between CD4+IL-10+expression and CD3+GR expression nor CD4+IL-10+expression and clinical outcome.</dc:description>
	<dc:publisher xml:lang="en">Journal of Tropical Life Science</dc:publisher>
	<dc:date>2014-12-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/220</dc:identifier>
	<dc:source xml:lang="en">Journal of Tropical Life Science; Vol. 4 No. 3 (2014); 166-174</dc:source>
	<dc:source>2527-4376</dc:source>
	<dc:source>2087-5517</dc:source>
	<dc:source>10.11594/jtls.4.3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/220/219</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2014 Journal of Tropical Life Science</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>